Adeshwar Meditex

Why is Adeshwar Meditex Ltd falling/rising?

As of N/A, the stock price of Adeshwar Meditex Ltd is at 17.00, with a recent rise of 6.25% over the past week and 13.33% over the past month, outperforming the Sensex. However, it has declined by 5.56% over the past year and significantly over three and five years, indicating mixed long-term performance despite recent short-term gains.

As of N/A, the stock price of Adeshwar Meditex Ltd is currently at 17.00, with no change noted (0.00%). However, examining the stock's performance over various periods reveals a mixed picture. Over the past week, the stock has risen by 6.25%, significantly outperforming the Sensex, which increased by only 0.75%. In the past month, the stock has also shown a strong gain of 13.33%, compared to the Sensex's modest rise of 1.29%.<BR><BR>Year-to-date, Adeshwar Meditex Ltd has maintained a gain of 6.25%, while the Sensex has declined by 8.30%. This indicates that the stock has been resilient in the face of broader market challenges. However, looking at the longer-term performance, the stock has fallen by 5.56% over the past year and has experienced significant declines of 26.09% over three years and 32.27% over five years, while the Sensex has shown positive returns in those periods.<BR><BR>Overall, the recent short-term gains suggest a rising trend for Adeshwar Meditex Ltd, driven by stronger performance relative to the benchmark index. However, the longer-term declines indicate underlying challenges that the company may face, which could affect future stock performance.

Which are the latest news on Adeshwar Meditex?

How big is Adeshwar Meditex?

As of 10th June, Adeshwar Meditex Ltd has a market capitalization of 23.00 Cr, classifying it as a Micro Cap company, with no valid financial data available for the latest four quarters. The latest balance sheet shows Shareholder's Funds of 36.96 Cr and Total Assets of 71.97 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Adeshwar Meditex Ltd has a market capitalization of 23.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 36.96 Cr and Total Assets valued at 71.97 Cr.

Who are in the management team of Adeshwar Meditex?

The management team of Adeshwar Meditex includes Ashalata Raut and Krishnojirao Nagaraja Rao as Whole-time Directors, Sucheta Talati and Shailesh Vinayak Rajpure as Directors, and Shivani Shivshankar Tiwari as Company Secretary.

The management team of Adeshwar Meditex includes the following individuals:<BR><BR>1. **Ashalata Raut** - Whole-time Director<BR>2. **Krishnojirao Nagaraja Rao** - Whole-time Director<BR>3. **Sucheta Talati** - Director<BR>4. **Shivani Shivshankar Tiwari** - Company Secretary<BR>5. **Shailesh Vinayak Rajpure** - Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

Who are the peers of the Adeshwar Meditex?

Adeshwar Meditex's peers include Chennai Meena, Tejnaksh Health, and Galaxy Medicare, among others. In terms of performance, Chennai Meena leads with a 1-year return of 17.93%, while Adeshwar Meditex has a return of -11.81%.

Peers: The peers of Adeshwar Meditex are Chennai Meena, Tejnaksh Health., Transgene Biotek, Family Care, Vanta Bioscience, Looks Health, Clinitech Lab, Dhanvantri Jeev., Galaxy Medicare, and Sunrest Lifescie.<BR><BR>Quality Snapshot: Excellent management risk is observed at Galaxy Medicare, while Average management risk is found at Family Care, and the rest have Below Average or do not qualify. Good growth is noted at Family Care, while Below Average growth is seen at Tejnaksh Health., Vanta Bioscience, Clinitech Lab, Dhanvantri Jeev., and Adeshwar Meditex, and the rest do not qualify. Average capital structure is present at Adeshwar Meditex, while Excellent capital structure is observed at Family Care, and Good capital structure is found at Tejnaksh Health., Clinitech Lab, Dhanvantri Jeev., and Galaxy Medicare, with the rest not qualifying.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Chennai Meena at 17.93%, while Tejnaksh Health. has the lowest at -34.31%. Adeshwar Meditex's 1-year return is -11.81%, which is better than Tejnaksh Health. but worse than Chennai Meena. Additionally, the peers with negative six-month returns include Chennai Meena, Tejnaksh Health., Family Care, Vanta Bioscience, Dhanvantri Jeev., and Galaxy Medicare.

When is the next results date for Adeshwar Meditex Ltd?

The next results date for Adeshwar Meditex Ltd is 21 May 2026.

The next results date for Adeshwar Meditex Ltd is scheduled for 21 May 2026.

Is Adeshwar Meditex overvalued or undervalued?

As of November 13, 2025, Adeshwar Meditex is considered undervalued with a favorable outlook, featuring a PE ratio of 11.33 and an EV to EBITDA of 6.75, significantly lower than its peers, despite a year-to-date stock underperformance of -37.5% compared to the Sensex's 8.11%.

As of 13 November 2025, Adeshwar Meditex has moved from a fair to an attractive valuation grade, indicating a more favorable outlook for the company. The stock is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 11.33, an EV to EBITDA of 6.75, and a Price to Book Value of 0.62, which suggest that the company is trading at a significant discount relative to its earnings and asset value.<BR><BR>In comparison to its peers, Adeshwar Meditex stands out with a much lower PE ratio than Poly Medicure, which has a PE of 55.2, and Blue Jet Health at 28.63. The EV to EBITDA ratio of 6.75 also highlights its attractiveness compared to other expensive peers like Laxmi Dental at 38.93. Despite the recent underperformance of Adeshwar Meditex's stock against the Sensex, with a YTD return of -37.5% compared to the Sensex's 8.11%, the current valuation metrics suggest that it presents a compelling investment opportunity.

How has been the historical performance of Adeshwar Meditex?

Adeshwar Meditex reported a net profit of 0.79 crore and net sales of 64.76 crore for the year ending March 2022, with an operating profit margin of 5.2%. Total liabilities and assets were both 72.45 crore, and the book value per share increased to 21.45.

Answer:<BR>The historical performance of Adeshwar Meditex shows a consolidated net profit of 0.79 crore for the year ending March 2022, with net sales recorded at 64.76 crore. The total operating income for the same period was also 64.76 crore, while total expenditure, excluding depreciation, amounted to 61.39 crore, resulting in an operating profit (PBDIT) of 3.60 crore. The profit before tax was 1.19 crore, leading to a profit after tax of 0.79 crore. The earnings per share (EPS) stood at 0.55, with a diluted EPS of 0.59. The operating profit margin was 5.2%, and the profit after tax margin was 1.22%. <BR><BR>In terms of balance sheet performance, the total liabilities as of March 2022 were 72.45 crore, with total assets also at 72.45 crore. The company's shareholder's funds were reported at 30.95 crore. Over the years, the book value per share has shown a steady increase, reaching 21.45 by March 2022. Cash flow from operating activities was negative at -2.00 crore for the year ending March 2022, while the net cash inflow/outflow was 0.00 crore. The company has maintained a consistent share capital of 14.43 crore since March 2021, indicating stability in its equity base.

What does Adeshwar Meditex do?

Adeshwar Meditex Ltd is a micro-cap company that manufactures and exports sterile surgical wound dressings and medical disposables. It was incorporated in 2007 and became a public company in 2021, with a market cap of INR 26 Cr.

Overview: <BR>Adeshwar Meditex Ltd is a leading manufacturer and exporter of sterile surgical wound dressings and medical disposables, operating within the healthcare services industry and classified as a micro-cap company.<BR><BR>History: <BR>Adeshwar Meditex Limited was incorporated as 'Adeshwar Meditex Private Limited' in 2007 and converted to a public limited company on March 09, 2021. There is no recent sales and profit data reported.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 26 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.36 <BR>Return on Equity: 5.93% <BR>Price-to-Book: 0.74 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Adeshwar Meditex?

The top shareholders of Adeshwar Meditex include Abhinandan N with 29.83%, Ashalata B Raut at 6.11%, and individual investors collectively owning 36.96%. There are no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of Adeshwar Meditex include the promoters, with Abhinandan N holding the largest share at 29.83%. The highest public shareholder is Ashalata B Raut, who holds 6.11%. Additionally, individual investors collectively own 36.96% of the company's shares. There are currently no mutual funds or foreign institutional investors holding shares in the company.